UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Cardiovascular revascularization medicine, ISSN 1553-8389, 12/2018, Volume 19, Issue 8, pp. 897 - 898
Journal Article
Clinical research in cardiology, ISSN 1861-0684, 4/2016, Volume 105, Issue 4, pp. 349 - 355
Prasugrel | Medicine & Public Health | Drug interactions | Morphine | Platelet function tests | Cardiology | Vasodilator-stimulated phosphoprotein | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Purinergic P2Y Receptor Antagonists - administration & dosage | Humans | Male | Purinergic P2Y Receptor Antagonists - blood | Drug Monitoring - methods | Healthy Volunteers | Platelet Aggregation Inhibitors - blood | Young Adult | Purinergic P2Y Receptor Antagonists - adverse effects | Tandem Mass Spectrometry | Austria | Analgesics, Opioid - adverse effects | Drug Interactions | Biotransformation | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Chromatography, Liquid | Adult | Female | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Prasugrel Hydrochloride - administration & dosage | Prasugrel Hydrochloride - pharmacokinetics | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Risk Assessment | Purinergic P2Y Receptor Antagonists - pharmacokinetics | Prasugrel Hydrochloride - adverse effects | Cross-Over Studies | Analgesics, Opioid - administration & dosage | Morphine - administration & dosage | Morphine - adverse effects | Prasugrel Hydrochloride - blood | Medical colleges | Metabolites | Vasodilators | Clinical trials | Liquid chromatography | Mass spectrometry | Index Medicus | Original Paper
Journal Article
Thrombosis and haemostasis, ISSN 0340-6245, 01/2016, Volume 116, Issue 7, pp. 96 - 102
Cellular Haemostasis and Platelets | Prasugrel | inhibitors | Morphine | Platelet reactivity | Antiplatelet medications | P2Y | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Humans | Middle Aged | Intestinal Absorption - drug effects | ST Elevation Myocardial Infarction - drug therapy | Male | ST Elevation Myocardial Infarction - blood | Cross-Over Studies | Platelet Aggregation Inhibitors - blood | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | ST Elevation Myocardial Infarction - surgery | Aged | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Prasugrel Hydrochloride - administration & dosage | Prasugrel Hydrochloride - pharmacokinetics | Morphine - administration & dosage | Morphine - adverse effects | Percutaneous Coronary Intervention | Prasugrel Hydrochloride - blood
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2016, Volume 67, Issue 17, pp. 1994 - 2004
crushed tablet | pharmacodynamic | pharmacokinetic | platelets | Prospective Studies | Tablets | Humans | Middle Aged | Male | ST Elevation Myocardial Infarction - therapy | Platelet Aggregation | Platelet Aggregation Inhibitors - blood | Receptors, Purinergic P2Y12 - blood | Platelet Aggregation Inhibitors - administration & dosage | Female | Platelet Aggregation Inhibitors - pharmacokinetics | Prasugrel Hydrochloride - administration & dosage | Prasugrel Hydrochloride - pharmacokinetics | Percutaneous Coronary Intervention | Prasugrel Hydrochloride - blood | Transluminal angioplasty | Medicine, Experimental | Medical research | Cardiology | Studies | Anticoagulants | Aspirin | Heart attacks | Blood platelets | Bioavailability | Acute coronary syndromes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2016, Volume 374, Issue 7, pp. 625 - 635
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Peripheral Vascular Diseases - prevention & control | Acute Chest Syndrome - etiology | Double-Blind Method | Pain - prevention & control | Administration, Oral | Anemia, Sickle Cell - complications | Humans | Child, Preschool | Male | Anemia, Sickle Cell - drug therapy | Prasugrel Hydrochloride - adverse effects | Prasugrel Hydrochloride - therapeutic use | Peripheral Vascular Diseases - etiology | Adolescent | Pain - etiology | Female | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - therapeutic use | Acute Chest Syndrome - prevention & control | Child | Platelet Aggregation Inhibitors - adverse effects | Care and treatment | Sickle cell anemia | Occlusion | Anemia | Clinical trials | Patients | Hemorrhage | Thrombosis | Pain | Blood platelets | Cell adhesion | Children | Sickle cell disease | Drug therapy | Adolescents | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 06/2019, Volume 321, Issue 24, pp. 2414 - 2427
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug-Eluting Stents | Drug Administration Schedule | Humans | Middle Aged | Male | Prasugrel Hydrochloride - adverse effects | Prasugrel Hydrochloride - therapeutic use | Aspirin - adverse effects | Female | Aged | Aspirin - therapeutic use | Clopidogrel - adverse effects | Hemorrhage - chemically induced | Clopidogrel - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Percutaneous Coronary Intervention | Purinergic P2Y Receptor Antagonists - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Aggregation | Aspirin | Dosage and administration | Blood platelets | Cardiovascular diseases | Drug therapy | Myocardial infarction | Cerebral infarction | Therapy | Surgical implants | Stroke | Clinical trials | Drug delivery | Criteria | Thrombosis | Hemorrhage | Patients | Bleeding | Ischemia | Implants | Clopidogrel | Thromboembolism | Stents | Index Medicus | Abridged Index Medicus | Original Investigation | Research
Journal Article
Thrombosis research, ISSN 0049-3848, 2016, Volume 143, pp. 141 - 148
Hematology, Oncology and Palliative Medicine | Prasugrel | P2Y12 inhibitors | Aspirin | ST elevation myocardial infarction | Platelet function assays | Primary percutaneous coronary intervention | STEMI | Clopidogrel | Ticagrelor | Inhibition of platelet activity (IPA) | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Prasugrel Hydrochloride - pharmacology | Adenosine - pharmacokinetics | Purinergic P2Y Receptor Antagonists - administration & dosage | Ticlopidine - pharmacology | Ticlopidine - therapeutic use | Humans | Adenosine - therapeutic use | Platelet Aggregation Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - pharmacology | Ticlopidine - administration & dosage | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Prasugrel Hydrochloride - administration & dosage | Platelet Aggregation Inhibitors - therapeutic use | Prasugrel Hydrochloride - pharmacokinetics | Purinergic P2Y Receptor Antagonists - therapeutic use | Myocardial Infarction - surgery | Purinergic P2Y Receptor Antagonists - pharmacology | Administration, Oral | Purinergic P2Y Receptor Antagonists - pharmacokinetics | Adenosine - pharmacology | Adenosine - administration & dosage | Ticlopidine - analogs & derivatives | Prasugrel Hydrochloride - therapeutic use | Myocardial Infarction - drug therapy | Adenosine - analogs & derivatives | Percutaneous Coronary Intervention | Heart attack | Index Medicus
Journal Article
European heart journal, ISSN 0195-668X, 01/2016, Volume 37, Issue 4, pp. 390 - 399
Myocardial infarction | Prasugrel | Clopidogrel | Stable coronary heart disease | Ticagrelor | Dual antiplatelet therapy | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Humans | Middle Aged | Treatment Outcome | Long-Term Care | Adenosine - administration & dosage | Secondary Prevention - methods | Ticlopidine - analogs & derivatives | Randomized Controlled Trials as Topic | Young Adult | Adenosine - analogs & derivatives | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - administration & dosage | Adult | Aged | Myocardial Infarction - prevention & control | Prasugrel Hydrochloride - administration & dosage | Drug Therapy, Combination | Index Medicus
Journal Article
Thrombosis and haemostasis, ISSN 0340-6245, 06/2017, Volume 117, Issue 8, pp. 1582 - 1587
Cellular Haemostasis and Platelets | Antiplatelet drugs | Pharmacodynamics | Pharmacokinetics | Intensive care unit | Platelet function | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Activation, Metabolic | Humans | Middle Aged | Critical Illness | Male | Microfilament Proteins - blood | Drug Monitoring - methods | Platelet Aggregation Inhibitors - blood | Austria | Phosphoproteins - blood | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Female | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Prasugrel Hydrochloride - administration & dosage | Blood Platelets - drug effects | Prasugrel Hydrochloride - pharmacokinetics | Drug Resistance | Platelet Aggregation Inhibitors - adverse effects | Cell Adhesion Molecules - blood | Treatment Outcome | Prasugrel Hydrochloride - adverse effects | Biomarkers - blood | Blood Platelets - metabolism | Prasugrel Hydrochloride - blood | pharmacokinetics | intensive care unit | platelet function | pharmacodynamics
Journal Article
The Lancet (British edition), ISSN 0140-6736, 10/2017, Volume 390, Issue 10104, pp. 1747 - 1757
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Myocardial Infarction - epidemiology | Acute Coronary Syndrome - epidemiology | Drug Administration Schedule | Hemorrhage - epidemiology | Humans | Middle Aged | Europe - epidemiology | Male | Prasugrel Hydrochloride - adverse effects | Ticlopidine - analogs & derivatives | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Acute Coronary Syndrome - therapy | Clopidogrel | Female | Stroke - epidemiology | Hemorrhage - chemically induced | Prasugrel Hydrochloride - administration & dosage | Drug Monitoring | Percutaneous Coronary Intervention | Platelet Aggregation Inhibitors - adverse effects | Transluminal angioplasty | Care and treatment | Coronary heart disease | Cardiac patients | Analysis | Anticoagulants | Heart attacks | Blood platelets | Angioplasty | Clinical trials | Acute coronary syndromes | Drug therapy | Patients | Evidence-based medicine | Clinical outcomes | Myocardial infarction | Intervention | Bleeding | Consortia | Randomization | Motivation | Inhibition | Cerebral infarction | Stroke | Test procedures | Health risks | Thrombosis | Coronary vessels | Biomarkers | Infarction | Cardiovascular diseases | Platelets | Index Medicus | Abridged Index Medicus
Journal Article